Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

The National Institutes of Health (NIH) is seeking applications for the Catalyze Program, which aims to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates. This specific initiative will provide early-stage translational support for the identification and characterization of potential therapeutic candidates and combination products to treat heart, lung, blood, and sleep disorders. The program will support research in the following areas: • Target identification and validation • Preliminary product/lead series identification • Development of small molecules, biologics, and combination products The program will provide funding for up to two years, with the possibility of renewal. Applicants must submit their applications electronically through the NIH website.